HOME >> BIOLOGY >> NEWS
UCR-led research team receives $5 million grant to study interaction of ecology and evolution

RIVERSIDE, Calif. -- An interdisciplinary team of researchers led by David Reznick, an evolutionary biologist at UC Riverside, has been awarded $5 million over five years by the National Science Foundation (NSF) to conduct an experimental study on how ecology a branch of science concerned with the interrelationship of an organism and its environment and evolution interact. The findings of the study are expected to help explain how environmental changes influence an organism's evolution as well as how the evolving organism, in turn, changes the ecosystem in which it is embedded.

Reznick, a professor of biology and the principal investigator of the grant from NSF's Frontiers in Integrative Biological Research (FIBR) program, in collaboration with colleagues specializing in molecular biology, population ecology, ecosystems science, biogeochemistry and applied mathematics, will perform the study of evolution/ecology interactions in natural stream communities on the island of Trinidad.

Specifically, the team will focus on guppies small fresh-water fish biologists have studied for long that coexist in the stream with Hart's killifish, a predator. The team will examine not only what causes the guppies to evolve as they might but also the co-evolution of the killifish.

"We know the fish are evolving, but the ecosystem they find themselves in is also changing," Reznick said. "It is popularly thought that evolution is so much slower than ecology that the two can be thought of as independent, but our results for guppies and those for other organisms show that evolution can be so fast that it happens on time scales that are similar to ecological interactions. If this is true, then changes in the ecosystem, such as the availability of resources or how many predators there are or the cycling of essential nutrients, can exert new evolutionary pressures on the guppies at the
'"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
6-Oct-2006


Page: 1 2 3

Related biology news :

1. UCR-led study identifies crucial mechanism involved in immune response against viruses
2. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
3. Saudi Arabias KAUST names WHOI first research partner
4. Multinational research: protecting ecology means understanding people, too
5. Newly created cancer stem cells could aid breast cancer research
6. Carnegie Mellons Peter Adams receives EPA research grant
7. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
8. Innovative tagging technique may help researchers better protect fish stocks
9. Penn researchers discover how key protein stops inflammation
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. ASU researchers partner with UOP to make biofuel for military jets a reality

Post Your Comments:
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: